Live Cell Imaging Market: Applications of HCS in personalized medicine
The global live
cell imaging market size is projected to reach USD 2.8 billion by 2025 from
USD 1.8 billion in 2020, at a CAGR of 8.8% during the forecast period.
The growing adoption of high-content screening techniques in
drug discovery, rising incidence of cancer, and the growth in funding for
research are the major factors driving the growth of this market.
The reagents segment
is expected...
Cell Surface Markers Market: High Growth Opportunities in Emerging Markets
The Cell Surface Markers Market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, growing at a CAGR of 8.1% during the forecast period.
The growth of this market is driven by factors such as the high global prevalence of cancer, growth in stem cell and neurobiology research, and the increasing funding for life sciences research.
Clinical...
Spatial Genomics Market – Top Driving Factors and Future Trends 2025
According to the new market research report Spatial Genomics Market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551Market
growth is largely driven by the increasing adoption of spatial genomics
and transcriptomics analysis among small...
Protein Assays Market worth 2.41 Billion USD by 2022
This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the protein assays market, along with revenue estimates & forecasts and market share analysis.
The global protein assays market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1% from 2017 to 2022. The increasing pharmaceutical...
Top 10 Cellular Analysis Market: Trends and Developments
The
major factors driving the growth of this market are the growing biotechnology
and biopharmaceutical industries, introduction of technologically advanced cell
analysis instruments, increasing incidence of infectious and chronic diseases
and rising number of patients suffering from cancer, and increasing investments
from various government associations & life sciences companies for cell
biology...
Primary Cells Market : Technological Advancements In The Field Of Monoclonal Antibodies
Major Growth Boosters:
Market growth is driven by the rising prevalence of cancer, increasing cancer research, rising investments in regenerative medicine research, rising demand for monoclonal antibodies, and rapid growth in the biotechnology and biopharmaceutical industries.
Expected Revenue Growth:
The global primary cells market is projected to reach USD 1,613 million by 2025...
CRISPR Technology Market: Pending Patent Issues & Results of Clinical Trials
The CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period.
The major factors driving the CRISPR technology market include the rising funding from government and private organizations and the high adoption of CRISPR technology.
The CRISPR products segment is expected to command the largest share of the...
Nucleic Acid Isolation and Purification Market to Witness Steady Growth in the Near Future
The growth of this
market can mainly be attributed to the increasing R&D activities as well as
technological advancements and increasing automation. On the other hand, the
high cost of automated instruments is expected to hinder the growth of the
market.
The Nucleic Acid Isolation and Purification Market is projected to reach USD 4.8 billion
by 2025 from USD 3.2 billion in 2020,...
Cancer Biomarkers Market to grow at a CAGR of 12.2%
The increasing prevalence of cancer, rising government support for
research on cancer biomarkers, growing use of biomarkers in drug
discovery and development, and increasing use of biomarker tests for
diagnostic purposes are the major factors that are driving the growth of
this market. According to research report the global cancer biomarkers market to reach USD 20.4 billion by 2022. and is estimated...
Creatinine Measurement Market: Commercialization of Advanced Testing Methods
The Creatinine Measurement Market is expected to reach USD 700.8 million by 2027 from USD 377.2 million in 2018, at a CAGR of 8.4%.
The increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, growing awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rising...